1.Analysis of the medication patterns of traditional Chinese medicine in treatment of radiotherapy-induced oral mucositis
Yongzhen LIU ; Ling WANG ; Furong LIU
China Modern Doctor 2025;63(19):81-84,91
Objective Based on data mining,the medication patterns and characteristics of traditional Chinese medicine compound in treatment of radiotherapy-induced oral mucositis(RIOM)were studied to provide references for clinical diagnosis and treatment.Methods Search for relevant literatures on the intervention of traditional Chinese medicine in RIOM published in databases such as CNKI,VIP,and Wanfang Data Knowledge Service Platform from their establishment to December 6,2024.High-frequency drug statistics,association rules,systematic clustering and complex network analysis were conducted using Excel 2010,SPSS Modeler 18.0 and Origin 2024 software.Results A total of 70 prescriptions involving 154 herbs were selected.There were 16 herbs with a frequency≥ 12,and the top 10 were Maidong,Shengdihuang,Shenggancao,Xuanshen,Jinyinhua,Beishashen,Lianqiao,Jiegeng,Taizishen,Fuling.The four qi were mainly cold,while the five flavors were mainly sweet and bitter.The channel tropism were most concentrated in lung meridian,stomach meridian,and heart meridian.Association rule analysis identified 10 commonly used drug pairs,systematic clustering yielded 5 novel drug combinations,and complex network analysis results were consistent with systematic clustering.Conclusion Traditional Chinese medicine treatment for RIOM mainly focuses on clearing heat and removing toxicity,supplement qi and nourish yin,while also promoting production of fluid,promoting blood circulation for removing blood stasis,and dispersing pathogenic factors.The new formulas obtained from data mining,such as Maidong,Beishashen,Yuzhu,Shihu,Tiandong,Jinyinhua,Lianqiao,Shenggancao,can provide good clinical reference.
2.Cost-Effectiveness Analysis of Endoscopic Screening of Upper Gastrointestinal Cancer in Yangcheng County,Shanxi Province in 2018
Dianhu RUAN ; Wangfei CUI ; Xinzheng WANG ; Licheng LYU ; Ling CAO ; Yongzhen ZHANG
China Cancer 2025;34(3):209-214
[Purpose]To analyze the cost-effectiveness of endoscopic screening for upper gastroin-testinal cancer in Yangcheng County of Shanxi Province.[Methods]People aged from 40 to 69 who participated in upper gastrointestinal cancer screening in Yangcheng County in 2018 were se-lected as the study subjects to participate in upper gastrointestinal cancer screening in 2018,and endoscopic examination with iodine staining and indicative biopsy were performed for screening.The detection rates of precancerous lesions and upper gastrointestinal malignancies,and early di-agnosis rates were calculated,and compared among different groups.The data of screening cost were collected;and the per capita screening cost,the average cost of early case detection and ear-ly detection cost index(EDCI)were calculated.[Results]Among 2 950 subjects undergoing en-doscopy,pathological biopsy was completed in 2 073 cases(70.27%),374 cases of precancerous le-sions(12.68%)and 52 cases of malignancies(1.76%)were detected,among which 17 cases were up-per gastrointestinal cancer with a detection rate of 0.58%,there were 44 early cases with an early diagnosis rate of 84.62%.The detection rate of precancerous lesions and positive cases in men was higher than that of women,but the early diagnosis rate of upper gastrointestinal cancer was lower than that of women;the detection rate of positive cases and digestive tract cancer of 50 years and above were higher than those of people aged 40 to 49.The cost of screening for one positive lesion was 25 528.85 CNY,the cost of screening for one early case was 30 170.46 CNY.The EDCI was 0.52,indicating a good cost-effective value.[Conclusion]The study shows that the early diagnosis and early treatment screening program of upper gastrointestinal cancer has achieved remarkable re-sults in Yangcheng County.The follow-up screening work should focus on men and people over 50 years old,and strengthen the publicity of upper gastrointestinal screening for cancer.
3.Analysis of the medication patterns of traditional Chinese medicine in treatment of radiotherapy-induced oral mucositis
Yongzhen LIU ; Ling WANG ; Furong LIU
China Modern Doctor 2025;63(19):81-84,91
Objective Based on data mining,the medication patterns and characteristics of traditional Chinese medicine compound in treatment of radiotherapy-induced oral mucositis(RIOM)were studied to provide references for clinical diagnosis and treatment.Methods Search for relevant literatures on the intervention of traditional Chinese medicine in RIOM published in databases such as CNKI,VIP,and Wanfang Data Knowledge Service Platform from their establishment to December 6,2024.High-frequency drug statistics,association rules,systematic clustering and complex network analysis were conducted using Excel 2010,SPSS Modeler 18.0 and Origin 2024 software.Results A total of 70 prescriptions involving 154 herbs were selected.There were 16 herbs with a frequency≥ 12,and the top 10 were Maidong,Shengdihuang,Shenggancao,Xuanshen,Jinyinhua,Beishashen,Lianqiao,Jiegeng,Taizishen,Fuling.The four qi were mainly cold,while the five flavors were mainly sweet and bitter.The channel tropism were most concentrated in lung meridian,stomach meridian,and heart meridian.Association rule analysis identified 10 commonly used drug pairs,systematic clustering yielded 5 novel drug combinations,and complex network analysis results were consistent with systematic clustering.Conclusion Traditional Chinese medicine treatment for RIOM mainly focuses on clearing heat and removing toxicity,supplement qi and nourish yin,while also promoting production of fluid,promoting blood circulation for removing blood stasis,and dispersing pathogenic factors.The new formulas obtained from data mining,such as Maidong,Beishashen,Yuzhu,Shihu,Tiandong,Jinyinhua,Lianqiao,Shenggancao,can provide good clinical reference.
4.Analysis of the therapeutic effect of precise disconnection of pargastric varices guided by endoscopic ultrasound for the treatment of esophagogastric variceal bleeding(20 cases)
Fulong ZHANG ; Jing XU ; Xiao LI ; Yan SHI ; Zongyuan ZHAN ; Yongzhen HU ; Chunhua ZHOU ; Qun ZHU ; Hai WANG ; Chaojun HUANG ; Hongyan YUAN ; Yuhong JIANG ; Yuandong ZHU
China Journal of Endoscopy 2025;31(8):85-90
Objective To explore the therapeutic effect of precise disconnection of pargastric varices guided by endoscopic ultrasound in the treatment of esophagogastric variceal bleeding.Method A retrospective analysis was conducted on 20 patients with cirrhosis esophagogastric variceal bleeding treated with endoscopic ultrasound-guided precise disconnection of pargastric varices from January 1,2024 to December 31,2024.The efficacy was analyzed.Result All 20 patients successfully completed the precise disconnection of pargastric varices under the guidance of endoscopic ultrasound.The injection of tissue gel combined with the placement of spring coils(14 cases)and the injection of tissue gel alone(4 cases)successfully blocked the pargastric varices.All patients did not experience perforation,esophageal and cardia stenosis,massive bleeding,septicemia,or ectopic embolization.One patient who received tissue gel alone had slight bleeding from the pargastric varices after surgery and improved after 3 days of treatment to reduce portal vein pressure.Another one patient who received tissue gel alone had a low-grade fever and normal body temperature after 3 days of anti-infection treatment.Conclusion Precise disconnection of pargastric varices under the guidance of endoscopic ultrasound has a good therapeutic effect on esophagogastric variceal bleeding,with fewer complications such as ectopic embolization,massive bleeding,infection,and perforation.However,close follow-up observation is still needed to address the issue of pargastric varices.
5.Cost-Effectiveness Analysis of Endoscopic Screening of Upper Gastrointestinal Cancer in Yangcheng County,Shanxi Province in 2018
Dianhu RUAN ; Wangfei CUI ; Xinzheng WANG ; Licheng LYU ; Ling CAO ; Yongzhen ZHANG
China Cancer 2025;34(3):209-214
[Purpose]To analyze the cost-effectiveness of endoscopic screening for upper gastroin-testinal cancer in Yangcheng County of Shanxi Province.[Methods]People aged from 40 to 69 who participated in upper gastrointestinal cancer screening in Yangcheng County in 2018 were se-lected as the study subjects to participate in upper gastrointestinal cancer screening in 2018,and endoscopic examination with iodine staining and indicative biopsy were performed for screening.The detection rates of precancerous lesions and upper gastrointestinal malignancies,and early di-agnosis rates were calculated,and compared among different groups.The data of screening cost were collected;and the per capita screening cost,the average cost of early case detection and ear-ly detection cost index(EDCI)were calculated.[Results]Among 2 950 subjects undergoing en-doscopy,pathological biopsy was completed in 2 073 cases(70.27%),374 cases of precancerous le-sions(12.68%)and 52 cases of malignancies(1.76%)were detected,among which 17 cases were up-per gastrointestinal cancer with a detection rate of 0.58%,there were 44 early cases with an early diagnosis rate of 84.62%.The detection rate of precancerous lesions and positive cases in men was higher than that of women,but the early diagnosis rate of upper gastrointestinal cancer was lower than that of women;the detection rate of positive cases and digestive tract cancer of 50 years and above were higher than those of people aged 40 to 49.The cost of screening for one positive lesion was 25 528.85 CNY,the cost of screening for one early case was 30 170.46 CNY.The EDCI was 0.52,indicating a good cost-effective value.[Conclusion]The study shows that the early diagnosis and early treatment screening program of upper gastrointestinal cancer has achieved remarkable re-sults in Yangcheng County.The follow-up screening work should focus on men and people over 50 years old,and strengthen the publicity of upper gastrointestinal screening for cancer.
6.Effect of sorafenib on the lesions and vascular growth factors in the mouse model of hepatic alveolar echinococcosis
Jide A ; Hongshuai PAN ; Kechang ZHAO ; Yongzhen WANG ; Linxun LIU ; Ying ZHANG ; Jingni ZHANG ; Jinping CHAI
Chinese Journal of Hepatobiliary Surgery 2025;31(6):453-457
Objective:To observe the effects of sorafenib on the lesions and vascular growth factors in the mouse model of hepatic alveolar echinococcosis.Methods:One hundred healthy female Kunming mice weighing (20±4) g were used to establish a model of alveolar echinococcosis infection by intraperitoneal injection of alveolar echinococcosis protoscoleces. After 6 weeks of feeding, the rats were divided into 5 groups, 15 rats in each group, which were given warm saline, albendazole (100 mg/kg), and sorafenib at high-dose (100 mg/kg), middle-dose (50 mg/kg) and low-dose (30 mg/kg) by gavage for 6 weeks, respectively. Eyeball blood and hepatic alveolar echinococcosis tissue were collected from the mice after the last administration, and the body weight of the mice and the lesion weight were weighed. The concentrations and expression levels of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor-A (VEGF-A) and vascular endothelial growth factor receptor-2 (VEGFR-2) in serum and lesion tissues were detected by enzyme-linked immunosorbent assay (ELISA) and Western blotting.Results:There was no statistically significant difference in the body weight of mice among the saline group, albendazole group and low-dose, medium-dose and high-dose sorafenib groups ( F=0.43, P=0.784). The ratios of lesion weight to body weight in the above groups were (0.057±0.009), (0.031±0.005), (0.033±0.005), (0.031±0.005), and (0.031±0.005), respectively. The saline group had a higher ratio than the other four groups, and the differences were statistically significant (all P<0.05). The relative expression levels of HIF-1α, VEGF-A, VEGFR-2, CD31 and CD34 detected by Western blotting in the saline group were all higher than those in the albendazole group and the high-dose, medium-dose and low-dose sorafenib groups, and the differences were statistically significant (all P<0.05). The relative expression levels of the above proteins in the medium-dose and high-dose sorafenib groups were lower than those in the albendazole group, and the relative expression levels of the above proteins in the high-dose sorafenib group were also lower than those in the medium-dose sorafenib group, and the differences were statistically significant (all P<0.05). The concentration levels of HIF-1α, VEGF-A and VEGFR-2 in serum of mice in each group detected by ELISA were consistent with those detected by Western blotting. Conclusion:Sorafenib inhibits the proliferation of alveolar echinococcosis in mice by suppressing the expression of angiogenic factors in alveolar echinococcosis lesions.
7.Application of next-generation sequencing in the field of non-hereditary dermatoses
Yongzhen HONG ; Qian WANG ; Junqin LIANG
Chinese Journal of Dermatology 2025;58(8):793-796
In recent years, the development of next-generation sequencing has brought a broad prospect for the investigation of the pathogenesis, signal pathways, and biomarkers of skin diseases. Due to the advantages in the recognition of nucleic acid sequences, next-generation sequencing can recognize not only microorganisms on normal skin surfaces, but also rare pathogens which were difficult to be identified before. This review summarizes the application of next-generation sequencing in non-hereditary dermatoses, aiming to explore their pathogenesis and improve their diagnosis.
8.Establishment and Evaluation of a Risk Prediction Model for Chronic Liver Failure Complicated by Primary Hepatocellular Carcinoma Before Intervention
Yuanzhen WANG ; Hongyan WEI ; Renhai TIAN ; Yongzhen CHEN ; Danqing XU ; Yingyuan ZHANG ; Lixian CHANG ; Chunyun LIU ; Li LIU
Journal of Kunming Medical University 2025;46(3):139-147
Objective To analyze the influencing factors of chronic liver failure in patients with primary hepatic carcinoma(PHC)before intervention,and to establish and evaluate a nomogram risk prediction model.Methods A retrospective analysis was conducted by collecting general data and clinical test data within 24 hours of admission for PHC patients.Univariate analysis and Lasso regression were used for variable selection,followed by multivariate logistic regression analysis to identify independent influencing factors for CLF before PHC intervention,leading to the establishment of a nomogram risk prediction model.The model was evaluated using the Hosmer-Lemeshow test,receiver operating characteristic(ROC)curve,calibration curve,clinical decision curve,and clinical impact curve.Result A total of 353 cases of PHC patients were collected,including 153 cases in the liver failure group and 200 cases in the non-liver failure group,with a prevalence rate of 43.3%.Variables selected by Lasso regression included gastrointestinal bleeding,prothrombin time(PT),albumin(ALB),total bilirubin(TBIL),and gamma glutamyl transferase(GGT).Multivariate logistic regression analysis showed that gastrointestinal bleeding(OR=13.549,95%CI:2.899~63.322,P=0.001),PT(OR=1.599,95%CI:1.282~1.995,P<0.001),TBIL(OR=1.016,95%CI:1.006~1.025,P=0.002),and GGT(OR=1.002,95%CI:1.000~1.003,P=0.028)were independent risk factors for chronic liver failure prior to PHC intervention,leading to the establishment of a nomogram risk prediction model.The Hosmer Lemeshow test showed that the model had a good fit(x2=6.152,P>0.05);the area under ROC was 0.902(0.869-0.934),with a sensitivity of 80.4%and a specificity of 87.5%.The calibration curve indicated that the model predicts chronic liver failure prior to PHC intervention with good consistency.Clinical decision curve analysis and clinical impact curve analysis showed that the model has good clinical utility within a certain threshold range.Conclusion Gastrointestinal bleeding,PT ≥16.05s,TBIL≥37.80 mmol/L,and GGT≥ 99.00 U/L are independent risk factors for the occurrence of chronic liver failure before PHC intervention.The established nomogram risk prediction model has certain clinical application value in predicting the risk of chronic liver failure before PHC intervention.
9.A promising novel local anesthetic for effective anesthesia in oral inflammatory conditions through reducing mitochondria-related apoptosis.
Haofan WANG ; Yihang HAO ; Wenrui GAI ; Shilong HU ; Wencheng LIU ; Bo MA ; Rongjia SHI ; Yongzhen TAN ; Ting KANG ; Ao HAI ; Yi ZHAO ; Yaling TANG ; Ling YE ; Jin LIU ; Xinhua LIANG ; Bowen KE
Acta Pharmaceutica Sinica B 2025;15(11):5854-5866
Local anesthetics (LAs), such as articaine (AT), exhibit limited efficacy in inflammatory environments, which constitutes a significant limitation in their clinical application within oral medicine. In our prior research, we developed AT-17, which demonstrated effective properties in chronic inflammatory conditions and appears to function as a novel oral LA that could address this challenge. In the present study, we further elucidated the beneficial effects of AT-17 in acute inflammation, particularly in oral acute inflammation, where mitochondrial-related apoptosis played a crucial role. Our findings indicated that AT-17 effectively inhibited lipopolysaccharide (LPS)-induced nerve cell apoptosis by ameliorating mitochondrial dysfunction in vitro. This process involved the inhibition of mitochondrial reactive oxygen species (mtROS) production and the subsequent activation of the NRF2 pathway. Most notably, improvements in mitochondria-related apoptosis were key contributors to AT-17's inhibition of voltage-gated sodium channels. Additionally, AT-17 was shown to reduce mtROS production in nerve cells through the Na+/NCLX/ETC signaling axis. In conclusion, we have developed a novel local anesthetic that exhibits pronounced anesthetic functionality under inflammatory conditions by enhancing mitochondria-related apoptosis. This advancement holds considerable promise for future drug development and deepening our understanding of the underlying mechanisms of action.
10.Design and validation of an automated testing system for essential performance parameters of ventilators.
Yongzhen LI ; Wei WANG ; Chunyuan ZHANG ; Xia ZHANG ; Zhenglong CHEN ; Zhaoyan HU
Journal of Biomedical Engineering 2025;42(1):164-173
Traditional manual testing of ventilator performance is labor-intensive, time-consuming, and prone to errors in data recording, making it difficult to meet the current demands for testing efficiency in the development and manufacturing of ventilators. Therefore, in this study we designed an automated testing system for essential performance parameters of ventilators. The system mainly comprises a ventilator airflow analyzer, an automated switch module for simulated lungs, and a test control platform. Under the control of testing software, this system can perform automated tests of critical performance parameters of ventilators and generate a final test report. To validate the effectiveness of the designed system, tests were conducted on two different brands of ventilators under four different operating conditions, comparing tidal volume, oxygen concentration, and positive end expiratory pressure accuracy using both the automated testing system and traditional manual methods. Bland-Altman statistical analysis indicated good consistency between the accuracy of automated tests and manual tests for all respiratory parameters. In terms of testing efficiency, the automated testing system required approximately one-third of the time needed for manual testing. These results demonstrate that the designed automated testing system provides a novel approach and means for quality inspection and measurement calibration of ventilators, showing broad application prospects.
Ventilators, Mechanical/standards*
;
Equipment Design
;
Humans
;
Automation

Result Analysis
Print
Save
E-mail